William J. Peters - Jul 7, 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Stock symbol
AMPH
Transactions as of
Jul 7, 2021
Transactions value $
-$90,439
Form type
4
Date filed
7/8/2021, 06:32 PM
Previous filing
May 20, 2021
Next filing
Aug 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $113K +10K +8.91% $11.33 122K Jul 7, 2021 Direct F1
transaction AMPH Common Stock Sale -$204K -10K -8.18% $20.37 112K Jul 7, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -10K -25.13% $0.00 29.8K Jul 7, 2021 Common Stock 10K $11.33 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 929 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.33 to $20.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares subject to the option are fully vested and immediately exercisable.